Brookline Capital Acquisition Corp Information
On January 28, 2021 Brookline Capital Acquisition Corp. announced the pricing of its $50,000,000 IPO and is now listed on the NASDAQ under the ticker symbol “BCACU”.
Brookline Capital Acquisition Corp is affiliated with Brookline Capital Markets, a boutique investment bank with extensive experience providing capital markets and advisory services to public and private life sciences, Special Purpose Acquisition Companies (“SPACs”), and other emerging growth enterprises.
Brookline’s senior leadership has a robust history of executing public and private investment banking transactions for healthcare clients across a variety of indications and stages of development, resulting in a track record of success. The Firm was co-founded by three former colleagues with deep roots on Wall Street. The team is led by seasoned professionals, each with more than 25 years of capital markets and advisory experience at some of the world’s most prominent financial institutions (e.g., Alex. Brown, Bear Sterns, Citi, Cowen, Credit Suisse, Deutsche Bank, Lazard, Leerink and OrbiMed).
Link to Brookline Capital Markets website: https://brooklinecapmkts.com